Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2024 Jan 23

PMID 38257828

Authors

Dokyun Kim

Chih-Jen Lai

Inho Cha

Jae U Jung

Affiliations

Soon will be listed here.

Abstract

SFTSV is an emerging tick-borne virus causing hemorrhagic fever with a case fatality rate (CFR) that can reach up to 27%. With endemic infection in East Asia and the recent spread of the vector tick to more than 20 states in the United States, the SFTSV outbreak is a globally growing public health concern. However, there is currently no targeted antiviral therapy or licensed vaccine against SFTSV. Considering the age-dependent SFTS pathogenesis and disease outcome, a sophisticated vaccine development approach is required to safeguard the elderly population from lethal SFTSV infection. Given the recent emergence of SFTSV, the establishment of animal models to study immunogenicity and protection from SFTS symptoms has only occurred recently. The latest research efforts have applied diverse vaccine development approaches-including live-attenuated vaccine, DNA vaccine, whole inactivated virus vaccine, viral vector vaccine, protein subunit vaccine, and mRNA vaccine-in the quest to develop a safe and effective vaccine against SFTSV. This review aims to outline the current progress in SFTSV vaccine development and suggest future directions to enhance the safety and efficacy of these vaccines, ensuring their suitability for clinical application.

Citing Articles

Low-temperature enhances production of severe fever with thrombocytopenia syndrome virus virus-like particles.

Loop I, Ke Y, Chen W, Tsai K, Hsu W, Fan Y Appl Microbiol Biotechnol. 2025; 109(1):56.

PMID: 40032680 PMC: 11876217. DOI: 10.1007/s00253-025-13436-y.

Investigating the reassortment potential and pathogenicity of the S segment in Akabane virus using a reverse genetics system.

Na E, Jeong C, Chae S, Oem J BMC Vet Res. 2025; 21(1):20.

PMID: 39815297 PMC: 11734451. DOI: 10.1186/s12917-024-04459-0.

Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandavirus.

Hicks P, Manzoni T, Westover J, Petch R, Roper B, Gowen B Vaccines (Basel). 2025; 12(12.

PMID: 39772063 PMC: 11728676. DOI: 10.3390/vaccines12121403.

Pathogen isolation and traceability analysis of a fatal case of severe fever with thrombocytopenia syndrome virus (SFTSV) infectious encephalitis in China.

Liu R, He F, Chen S, Wang J, Yang C, Zhan Z Virol J. 2024; 21(1):300.

PMID: 39578877 PMC: 11585235. DOI: 10.1186/s12985-024-02564-y.

Knowledge mapping of severe fever with thrombocytopenia syndrome: a bibliometric analysis.

Zhang H, Zhang L Front Microbiol. 2024; 15:1423181.

PMID: 39139373 PMC: 11319145. DOI: 10.3389/fmicb.2024.1423181.

References

Jo Y, Kang J, Chae J, Cho Y, Shin J, Jheong W . Prevalence of Severe Fever with Thrombocytopenia Syndrome Virus in Ticks Collected from National Parks in Korea. Vector Borne Zoonotic Dis. 2018; 19(4):284-289. DOI: 10.1089/vbz.2018.2338. View

Kozak M, Hu J . The Integrated Consideration of Vaccine Platforms, Adjuvants, and Delivery Routes for Successful Vaccine Development. Vaccines (Basel). 2023; 11(3). PMC: 10055765. DOI: 10.3390/vaccines11030695. View

Kelly H, Tan H, Juno J, Esterbauer R, Ju Y, Jiang W . Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation. JCI Insight. 2020; 5(10). PMC: 7259527. DOI: 10.1172/jci.insight.136653. View

Liu W, Lu Q, Cui N, Li H, Wang L, Liu K . Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome. Clin Infect Dis. 2013; 57(9):1292-9. DOI: 10.1093/cid/cit530. View

Okada A, Hotta A, Kimura M, Park E, Morikawa S, Inoshima Y . A retrospective survey of the seroprevalence of severe fever with thrombocytopenia syndrome virus in wild animals in Japan. Vet Med Sci. 2020; 7(2):600-605. PMC: 8025650. DOI: 10.1002/vms3.400. View

Zhang L, Peng X, Wang Q, Li J, Lv S, Han S . CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus. Sci Adv. 2023; 9(31):eadg6856. PMC: 10396298. DOI: 10.1126/sciadv.adg6856. View

Kim D, Kim E, Kim S, Chung Y, Lai C, Cha I . Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of in aged ferrets. mBio. 2023; 14(5):e0186823. PMC: 10653821. DOI: 10.1128/mbio.01868-23. View

Hu Q, Zhang Y, Jiang J, Zheng A . Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step. Viruses. 2023; 15(3). PMC: 10052781. DOI: 10.3390/v15030800. View

Shen S, Duan X, Wang B, Zhu L, Zhang Y, Zhang J . A novel tick-borne phlebovirus, closely related to severe fever with thrombocytopenia syndrome virus and Heartland virus, is a potential pathogen. Emerg Microbes Infect. 2018; 7(1):95. PMC: 5970217. DOI: 10.1038/s41426-018-0093-2. View

10.

Rodriguez S, Cross R, Fenton K, Bente D, Mire C, Geisbert T . Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever. Sci Rep. 2019; 9(1):7755. PMC: 6533279. DOI: 10.1038/s41598-019-44210-6. View

11.

Sun J, Min Y, Li Y, Sun X, Deng F, Wang H . Animal Model of Severe Fever With Thrombocytopenia Syndrome Virus Infection. Front Microbiol. 2022; 12:797189. PMC: 8787146. DOI: 10.3389/fmicb.2021.797189. View

12.

Escribano-Romero E, Jimenez de Oya N, Domingo E, Saiz J . Extinction of West Nile Virus by Favipiravir through Lethal Mutagenesis. Antimicrob Agents Chemother. 2017; 61(11). PMC: 5655064. DOI: 10.1128/AAC.01400-17. View

13.

Takayama-Ito M, Saijo M . Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection. Front Microbiol. 2020; 11:150. PMC: 7026129. DOI: 10.3389/fmicb.2020.00150. View

14.

Domnich A, Arata L, Amicizia D, Puig-Barbera J, Gasparini R, Panatto D . Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis. Vaccine. 2016; 35(4):513-520. DOI: 10.1016/j.vaccine.2016.12.011. View

15.

Wormser G, McKenna D, Piedmonte N, Vinci V, Egizi A, Backenson B . First Recognized Human Bite in the United States by the Asian Longhorned Tick, Haemaphysalis longicornis. Clin Infect Dis. 2019; 70(2):314-316. DOI: 10.1093/cid/ciz449. View

16.

Zhou H, Sun Y, Wang Y, Liu M, Liu C, Wang W . The nucleoprotein of severe fever with thrombocytopenia syndrome virus processes a stable hexameric ring to facilitate RNA encapsidation. Protein Cell. 2013; 4(6):445-55. PMC: 4875558. DOI: 10.1007/s13238-013-3901-4. View

17.

Jin C, Jiang H, Liang M, Han Y, Gu W, Zhang F . SFTS virus infection in nonhuman primates. J Infect Dis. 2014; 211(6):915-25. DOI: 10.1093/infdis/jiu564. View

18.

Rattanakomol P, Khongwichit S, Linsuwanon P, Lee K, Vongpunsawad S, Poovorawan Y . Severe Fever with Thrombocytopenia Syndrome Virus Infection, Thailand, 2019-2020. Emerg Infect Dis. 2022; 28(12):2572-2574. PMC: 9707585. DOI: 10.3201/eid2812.221183. View

19.

Zhuang L, Sun Y, Cui X, Tang F, Hu J, Wang L . Transmission of Severe Fever with Thrombocytopenia Syndrome Virus by Haemaphysalis longicornis Ticks, China. Emerg Infect Dis. 2018; 24(5). PMC: 5938789. DOI: 10.3201/eid2405.151435. View

20.

Yu X, Liang M, Zhang S, Liu Y, Li J, Sun Y . Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011; 364(16):1523-32. PMC: 3113718. DOI: 10.1056/NEJMoa1010095. View